Cognitive Dysfunction and Delirium After TUR-M in Elderly Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorMuğla Sıtkı Koçman University

About this trial

Elderly patients undergoing transurethral resection are at increased risk of postoperative cognitive dysfunction (POCD) and delirium, which are associated with prolonged hospital stay, increased morbidity, and decreased quality of life. Identifying patients who are more likely to develop postoperative cognitive dysfunction or delirium remains a practical challenge in daily clinical practice. Better recognition of these patients may help tailor perioperative care and improve outcomes.

This prospective observational study aims to identify perioperative factors associated with POCD and delirium in elderly patients undergoing transurethral resection and to develop a clinically applicable risk prediction model. Cognitive function and delirium are assessed using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM).

Cognitive function and delirium will be evaluated using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM).

The results of this study may support clinicians in recognizing vulnerable patients earlier and may contribute to more individualized perioperative management.

Eligibility criteria

Qualifiers

Age ≥65 years

Scheduled for transurethral resection procedure

ASA physical status I-III

Able to provide informed consent

Disqualifiers

Pre-existing diagnosis of dementia or severe cognitive impairment (MoCA <18)

Severe visual or hearing impairment preventing cognitive assessment

History of psychiatric disease requiring antipsychotic or sedative medication

Neurological disorders associated with increased delirium risk (e.g., Parkinson's disease, epilepsy)

Trial design

Treatments tested in this trial

  • Cognitive and Delirium Assessment (MoCA and CAM)

Treatment groups

No treatment groups listed